QualityStocksNewsBreaks – Sharing Services Inc. (SHRG) Continues Record-Breaking Streak

Diversified holdings company Sharing Services Global Corporation (OTCQB: SHRG) is on a roll for breaking records, including achieving a ninefold increase in 2019 from its 2018 sales numbers. An article further discussing the company reads, “Sharing Services’ numbers also continue to grow. The company, which is dedicated to selling products directly to consumers, has posted record-breaking sales since its December 2017 release of a line of health and wellness products (http://ibn.fm/WtbDh). The company’s sales total of $85.9 million for its fiscal year ended April 30, 2019 (http://ibn.fm/4VG4J), represents a ninefold increase, or a $77.5 million jump, from SHRG’s FY2018 sales of $8.4 million.”

To view the full article, visit http://ibn.fm/308yk

About Sharing Services Global Corporation

Sharing Services Global Corporation, formerly Sharing Services Inc., is a diversified holding company that is publicly traded and dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies in the direct-selling industry. The Sharing Services combined platform leverages the capabilities and expertise of various companies that market and sell products direct to the consumer through independent contractors. Two of its primary divisions include Elevacity Global LLC, a product-sourcing and supply company, and Elepreneur LLC, a sales and marketing company based on utilization of independent contractors as the sales force. For more information, visit the company’s websites at www.SHRGinc.com, www.Elevacity.com or www.Elepreneur.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Trxade Group Inc. (TRXD) Aiding in Fight to Keep Independent Pharmacies Open

Integrated pharmaceutical services company Trxade Group (OTCQB: TRXD) is helping to sustain independent pharmacies through its web-based purchasing platform, network of locally run pharmacies, data analytics and delivery services. An article discussing the company reads, “A key challenge to the existence of independent pharmacies in the modern era is the capacity that larger drug store chains have for buying pharmaceutical products in bulk, thereby getting larger supplies at reduced costs. Those difficulties have been exacerbated as the pharmacy benefit managers (PBMs) designed to process claims for pharmacies have turned to working for Medicare, Medicaid and commercial health plans — their aim now to manage pharmaceutical benefits and keep insurers’ costs low (http://ibn.fm/CniN7). . . . A news media series of reports on ‘pharmacy deserts’ cropping up across Ohio and elsewhere in the United States (http://ibn.fm/11Fpk) as independent businesses close their doors expresses particular concern about the strain created by low reimbursement rates for state Medicaid patient coverage. Even many physicians are turning away potential patients over the state insurers’ record of poor reimbursement and complicated procedures for obtaining reimbursement (http://ibn.fm/sw932).”

To view the full article, visit http://ibn.fm/QqJkK

About Trxade Group Inc.

Headquartered in Tampa, Florida, Trxade Group is an integrated, pharmaceutical-logistical services company that combines a web-based purchasing platform for transactions between independent pharmacists and drug manufacturers, E-Hub with a mail-order pharmacy, warehouse and drug-delivery services for consumers nationwide. The company has over 10,500 registered independent pharmacies on its web-based market platform that enables the pharmacies to quickly and cost effectively source and purchase pharmaceuticals, accessories and services from a wide range of manufacturers and drug distributors. For more information, visit the company’s website at www.TrxadeGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to TRXD are available in the company’s newsroom at http://ibn.fm/TRXD

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Releases Q2 2019 Results and Provides Operational Update

Willow Biosciences (CSE: WLLW) today released its financial results for the three and six months ended June 30, 2019 and provided an operational update. Among highlights for the quarter, the company reported that it has: expanded its operations to include three facilities located in Calgary, Alberta, Mountain View, California and Burnaby, British Columbia; made key appointments to its management team and board of directors; entered an exclusive Joint Development Agreement (“JDA”) with Noramco; and completed a reverse takeover and raised gross proceeds of approximately $37.0 million. “Over the past few months, we have made impressive progress in advancing our business on several important fronts,” Willow President and Chief Executive Officer Trevor Peters said in the news release. “We have assembled a team of proven business executives and world-renowned scientists to lead the development of our high-quality consumer, wellness, and pharmaceutical ingredient manufacturing programs. The development of our yeast-based cannabinoid production platform is progressing well and we expect to initiate the scaling up of our process in the first half of 2020. In addition to advancing our development operations, we are focused on positioning Willow for successful future commercialization through our recently signed strategic partnership with Noramco, Inc. (Noramco), one of the world’s leading pharmaceutical cannabinoid ingredient producers.”

To view the full press release, visit http://ibn.fm/TiRkj

About Willow Biosciences Inc.

Headquartered in Calgary, Canada, Willow and its team of scientists are leaders in the field of biosynthetic production of high-value, plant-derived compounds. Willow has applied its integrated suite of technologies to develop manufacturing processes for numerous active pharmaceutical ingredients with various therapeutic benefits, including cancer treatment, pain management and CNS disorders. In the cannabinoid field, Willow owns proprietary, yeast-based lab strains that produce CBD, tetrahydrocannabinol (THC) and cannabigerol (CBG), as well as certain minor and novel cannabinoids. For more information, visit the company’s website at www.WillowBio.com.

NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://ibn.fm/WLLW

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Sharing Services Global Corporation (SHRG) Focuses on Empowering Entrepreneurs in Direct-Selling Industry

• The direct-selling industry is seeing rapid global growth with the ongoing shift toward a gig economy
• Sharing Services aims to empower independent business leaders to take charge of their own lives while creating record-breaking sales
• The company’s products utilizing dopamine, oxytocin, serotonin and endorphins create elevated happiness levels and are well-received by the market

The direct-selling industry has seen rapid growth globally. Estimated retail sales in 2018 marked a 1.2 percent increase over the previous year, bringing in $192.9 billion (http://ibn.fm/V16x9). More and more people are relying on gig jobs that allow them to avoid long commutes to the office, restricted work hours and bosses. Sharing Services Global Corporation (OTCQB: SHRG) is one of many companies making these conveniences possible in this emerging gig economy, but SHRG stands apart from the others due to its commitment to thoroughly empowering the home-based entrepreneur.

The company calls its independent distributors ‘Elepreneurs’, and it is reshaping the industry by providing necessary tools that can lead individuals to success. From its headquarters in Plano, Texas, the company provides Elepreneurs with quality training, products and services. All of the company’s sales are through organic growth, which is attributed to the Elepreneurs, who are effectively following the company’s Blue Ocean Strategy. Since 2017, the company has added thousands of independent distributors and continues to see growth.

Elepreneurs are focused on elevating their own lives and the lives of customers through products and services. By empowering entrepreneurs to take the reins of their own lives, Sharing Services has created a simpler, more inventive approach to sales and marketing that harnesses the power of relationship marketing. Today’s consumers are reached through cost-effective and personal approaches that other organizations have lacked the ability to accommodate. SHRG Elepreneurs are taught how to connect with others, utilize social media tools and grow organic friendships through excellent customer service. These skills in utilizing customers’ online presence to cultivate personal connections are setting Elepreneurs LLC apart from other direct-selling companies.

SHRG also has a competitive advantage as it taps into the health and wellness market. Wellness products make up an estimated 33.8 percent of America’s direct-selling industry. Synergizing the customer service talents of Elepreneurs with SHRG’s happiness-stimulating products, the company has been able to increase its products’ market penetration.

These products, which are designed to elevate the happiness and well-being of customers, have been created through SHRG’s wholly owned subsidiary, Elevacity LLC. The brand is made up of core products in the nutritional category, including supplements that incorporate the company’s formulation of dopamine, oxytocin, serotonin and endorphins, or D.O.S.E. These four hormones have been shown to promote well-being and happiness.

Backed by scientific data and well-known happiness researcher Shawn Achor (http://ibn.fm/yeP5F), the D.O.S.E. products have been well received and are a large reason for SHRG’s record-breaking sales since the products debuted in December 2017. Whether customers start their day with a D.O.S.E. of happiness mixed with their coffee or in a supplement, they know they are using a product that’s made with the highest standards.

SHRG seems to have found its niche as it focuses on creating products and services that impact the happiness of customers, entrepreneurs and investors alike.

For more information, visit the company’s website at www.SHRGInc.com

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Appoints New Member to Scientific Advisory Board

Endonovo Therapeutics (OTCQB: ENDV), a commercial-stage developer of noninvasive Electroceutical® therapeutic devices, this morning announced the appointment of orthopedic surgeon Dr. Geoffrey Abrams to its scientific advisory board. Dr. Abrams is an assistant professor of orthopedic surgery at the Stanford University School of Medicine as well as the director of sports medicine for Stanford’s varsity athletes. “We are thrilled to announce that Dr. Abrams is joining the Endonovo family by serving on the scientific advisory board. His participation will be instrumental as we continue to introduce the SofPulse® technology to post-surgical care to fight the opioid epidemic,” Endonovo CEO Alan Collier stated in the news release. “We look forward to working with Dr. Abrams’ team in designing a clinical trial of SofPulse® for post-operative pain and evaluating functional outcomes in shoulder surgery. We believe such a study will further validate the SofPulse® technology application across the orthopedic indications. This is a fantastic relationship and I could not be more pleased about Dr. Abrams’ enthusiasm and interest in helping his own patients as well as studying the technology for other indications as we plan expansion of the label in the future.”

To view the full press release, visit http://ibn.fm/ePqye

About Endonovo Therapeutics Inc.

Endonovo Therapeutics is a commercial-stage developer of noninvasive wearable Electroceutical® therapeutic devices. The company’s current portfolio of commercial and clinical-stage wearable Electroceuticals® therapeutic devices addresses wound healing, pain, postsurgical pain and edema, cardiovascular disease, chronic kidney disease and central nervous system (“CNS”) disorders, including traumatic brain injury (“TBI”), acute concussions, postconcussion syndrome and multiple sclerosis. The company’s noninvasive Electroceutical® therapeutic device, SofPulse®, using pulsed short-wave radiofrequency at 27.12 MHz, has been FDA cleared and CE marked for the palliative treatment of soft-tissue injuries and postoperative pain and edema, and has CMS national coverage for the treatment of chronic wounds. The company’s current portfolio of preclinical-stage Electroceuticals® therapeutic devices address chronic kidney disease, liver disease nonalcoholic steatohepatitis (“NASH”), cardiovascular and peripheral artery disease (“PAD”), and ischemic stroke. The company’s noninvasive, wearable Electroceuticals® therapeutic devices work by restoring key electrochemical processes that initiate anti-inflammatory and growth-factor cascades necessary for healing to occur. For more information, visit the company’s website at www.Endonovo.com.

NOTE TO INVESTORS: The latest news and updates relating to ENDV are available in the company’s newsroom at http://ibn.fm/ENDV

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – SinglePoint, Inc. (SING) CEO and President Discuss Solar Acquisition on MoneyTV with Donald Baillargeon

Technology and investment company SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally-syndicated program is all about money and what makes it happen, featuring various companies and in-depth CEO and executive interviews that offer insights into operations and future outlooks. MoneyTV is viewed in over 200 million households in more than 75 countries. This week’s program featured SinglePoint CEO Greg Lambrecht and President Will Ralston as they discussed revenues from the company’s solar acquisition.

To view the full press release, visit http://ibn.fm/Qcws9

About SinglePoint, Inc.

SinglePoint, Inc. is a technology and investment company with a focus on acquiring companies that will benefit from the injection of growth capital and technology integration. The company portfolio includes mobile payments, ancillary cannabis services and blockchain solutions. Through acquisitions into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued companies, thereby providing a rich, diversified holding base. Through SingleSeed, the company is providing products and services to the cannabis industry. For more information, visit the company’s website at www.SinglePoint.com.

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://ibn.fm/SING

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Committed to Developing Most Effective Proprietary Cannabis Strains and Products

• The company recently completed clinical trials for its acute pain formulation, CTL-X, which is the most advanced product in the Veritas pipeline
• Veritas Pharma works in two directions to put together effective cannabis-based treatments for various medical conditions
• With the help of R&D partner Cannevert Therapeutics, Veritas is developing solutions for various additional issues like chronic pain and sleep disorders

Pharmaceutical and IP development company Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) is on a mission to develop the most effective proprietary cannabis strains and products for the treatment of various medical conditions. The company focuses on providing both physicians and patients with conclusive evidence for the recommendation of medical marijuana.

In the spring of 2019, Veritas announced the results of its product clinical trials in support of the company’s commitment to developing the most effective products (http://ibn.fm/dgy4C). The cannabis treatment clinical trial (randomized, double-blinded, cross-over) tested the effectiveness of the company’s vaporized CTL-X acute pain product. Studies were carried out following GMP standards over the course of three months. The results provide real scientific evidence of the use of cannabis for medical purposes and, more specifically, for the treatment of acute pain.

“We believe that for millions of people suffering from acute pain vaporized cannabis can potentially reduce the need for other medications, including opioids. From results of this study, clinicians will have a better understanding for specific dosage and delivery of cannabis for acute pain,” Veritas Medical Director Dr. Scott Alexander stated in a news release.

Veritas’ innovative research and development approach aims to solve the critical need for scientific research to support claims about the effectiveness of cannabis-based treatments. Through its research and development subsidiary, Cannevert Therapeutics Ltd., Veritas is developing innovative products for the treatment of various medical conditions like chronic and acute pain, sleep disorders and palliative care.

Cannevert has screened numerous cannabis strains to pinpoint their potential in treating chronic pain and reducing the need for opioid administration. Acute pain treatment CTL-X is the most advanced product in the Veritas pipeline and therefore the focus of its clinical trial efforts.

Veritas is also concerned with sleep disorders and the growing prominence of the conditions. Studies show that Americans are now getting one to two hours less sleep than previous generations (http://ibn.fm/yIp3V). In 1942, only 11 percent of Americans slept six hours or less per night. By 2013, the number had increased to 40 percent of the adult population, the American Association of Retired Persons (AARP) reported.

Through its research, Veritas is attempting to identify cannabis as a reliable solution to this growing problem. There is some anecdotal evidence, and Cannevert is working to develop biological assays to identify the most effective strain for the treatment of insomnia, parasomnia, chronic fatigue syndrome and others.

Based at the University of British Columbia, Cannevert has brought together a team of pharmacologists, chemists and anesthetists who have substantial prior experience in drug development. Through the partnership, Veritas gains the technical ability to achieve its effective treatment development vision.

For more information, visit the company’s website at www.VeritasPharmaInc.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)

Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – ORHub, Inc. (ORHB) Announces 90-Day Stay of Litigation

ORHub (OTC: ORHB), a Microsoft Silver Partner and cloud-based healthcare intelligence company focused on the business of surgery, today announced its receipt of confirmation from the courts granting a 90-day stay of litigation while the company and certain shareholders make efforts to negotiate a fair resolution to a contractual dispute arising out of the Series 2017 A 12% Note Agreement. “I am pleased with the progress the company has made so far working with these former note holders in finding an equitable resolution that addresses their concerns,” ORHub Chairman and CEO Dr. Robert “Bobby” Lazzara said in the news release. “Our number one goal is to maximize the value of our shareholders, while managing the interests and concerns of all our constituents.”

To view the full press release, visit http://ibn.fm/Zp9At

About ORHub, Inc.

ORHub is a growth stage data analytics company on a mission to optimize the Business of Surgery through lean process improvement. As a Microsoft Silver Partner, ORHub leverages the Azure cloud to help customers unlock the power in their data captured in the OR. Surgical Spotlight® helps providers harness that data, identify millions of dollars in opportunities, and get leaders back to their primary focus: improving care, increasing patient access and reducing costs. A first-of-kind team building tool brings all stakeholders together with regular and accessible information. ORHub specializes in business intelligence for the operating room, built by professionals from the operating room. For more information, visit the company’s website at www.ORHub.com.

NOTE TO INVESTORS: The latest news and updates relating to ORHUB are available in the company’s newsroom at http://ibn.fm/ORHUB

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Trxade Group Inc. (TRXD) Helps Keep Lifeblood of Nation’s Independent Pharmacies Flowing

• Trxade Group’s supplier-to-pharmacy network, delivery services and data analytics platform are empowering independent pharmacies struggling to stay in business amid competitive challenges
• The company reported record revenues of $1.9 million for the most recent quarter, as well as other improvements to its top and bottom lines
• The plight of independent pharmacies has caught the attention of state officials in Illinois, who recently enacted Illinois’ first oversight system for the middlemen who manage pharmacy costs and reimbursement rates

Independent pharmacies in Illinois are celebrating recent state legislative action that strengthens small businesses involved in dispensing quality of life-enhancing medications to their customers, an empowerment trend that pharmaceutical services company Trxade Group Inc. (OTCQB: TRXD) has taken to heart as it builds its own growing network of independent pharmacies across the country.

Many of those mom-and-pop pharmacies have found it necessary to close up shop due to a variety of economic conditions, creating what have come to be known as ‘pharmacy deserts’, where residents remain without close-to-home options for fulfilling their prescription needs, especially if they are looking for a familiar business that knows its neighbors and goes the extra mile to assist them (http://ibn.fm/EVkGM).

Low insurer reimbursement rates have become a common complaint among community-oriented small business pharmacies nationwide. Several pharmacists have blamed the pharmacy benefit manager (PBM) middlemen who negotiate costs between pharmacies and insurers, such as Medicare, Medicaid and commercial health plans, arguing that the PBMs improperly drive up the costs of doing business and thereby force small pharmaceuticals out of business (http://ibn.fm/BGoRl).

Trxade’s network offers a platform for buying medications at competitive prices, as well as services for storing pharmaceuticals and delivering them directly to consumers, with an aim of helping sustain independent pharmacists amid their industry difficulties. Illinois’ legislature provided additional relief that was hailed by the Illinois Pharmacists Association in August by passing a bill that creates its first oversight system for PBMs, as reported by The State Journal-Register (http://ibn.fm/XtEA3). The state has also budgeted millions of dollars for pharmacy assistance out of concern for the small, independent shops, the report states.

Michelle Dyer, who operates three Michelle’s Pharmacy stores in the state, applauded the new law as “a great step to reign in the abusive powers that PBMs use against independent pharmacies,” adding that PBMs are “creating unprofitable environments that make it difficult to sustain business for independent pharmacies, and the result is that we’re seeing these businesses closing all the time in central Illinois,” according to the report.

Trxade’s own private enterprise approach to keeping the lifeblood flowing in independent pharmacies’ veins has seen its financial top and bottom lines grow. Its most recent quarterly report displays record revenue growth, as well as an increase in gross profits and a growing number of subscribers to the pharmacy network.

The company reported that revenues for the three months ended June 30 were over $1.9 million, marking an increase of 129 percent year-over-year. It also marked a 27 percent sequential increase over the first quarter ended March 31 (http://ibn.fm/hOCza).

“We made excellent progress executing against our key strategic priorities in our Delivmeds.com program, our B2C commercial efforts and our proprietary B2B trading platform www.Trxade.com,” Chairman and CEO Suren Ajjarapu stated in a news release. “Accordingly, I am optimistic that our new product lines will generate profitability as increasing pharmaceutical prices drive independent pharmacies, payors and consumers to be more aggressive in sourcing medication.”

For more information, visit the company’s website at www.TrxadeGroup.com

NOTE TO INVESTORS: The latest news and updates relating to TRXD are available in the company’s newsroom at http://ibn.fm/TRXD

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Reports Unaudited Q2 2019 Results

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a leading cannabis branded products company in the U.S., today released its unaudited financial and operational results for the three and six months ended June 30, 2019. In the update, the company reported second quarter financial highlights including the following: Revenue increase to $3.6 million in Q2 2019, representing 125% year-over-year growth over Q2 2018 revenues of $1.6 million; improvement in gross margins to $0.7 million, or 20%, in Q2 2019, compared with $0.2 million, or 14%, in Q2 2018. “Our high product standards, growing brand recognition and the launch of our new line of mints drove strong demand for our products this quarter, cementing our position as a top selling cannabis brand in California,” Plus Products Co-Founder and Chief Executive Officer Jake Heimark said in the news release. “For the 5th consecutive quarter, PLUS ‘Uplift’ was the #1 best-selling cannabis product in California in dollars sold, according to data from BDS Analytics.”

To view the full press release, visit http://ibn.fm/M95af

About Plus Products Inc.

Plus Products is a California edibles company focused on using nature to bring balance to consumers lives. PLUS’s mission is to make cannabis safe and approachable; that mission begins with high-quality products that deliver consistent consumer experiences. PLUS Gummies and PLUS Mints are manufactured at PLUS’s own factory in Adelanto, California, with strict internal and external testing to ensure accurate consistent dosage. PLUS is headquartered in San Mateo, California, with 80 employees. For more information, visit the company’s website at www.PlusProducts.com.

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://ibn.fm/PLPRF

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) CEO Rings Nasdaq Opening Bell

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of augmented reality interactive entertainment games and toys in China, today announced that its CEO Xiaodong Chen rang the Nasdaq opening bell at 9:30 AM ET on August 30, 2019, signifying the start of today’s trade. BHAT executives, employees and directors joined Chen for the Market Bell Ceremony. “We are honored and excited to participate in the opening bell ceremony at Nasdaq,” BHAT CEO Xiaodong Chen said in the news release. “Our initial public offering completed in July 2019 represents a new start of our company, and we look forward to enhancing our user experience by launching innovative new products with our proprietary AR technology in the future.”

To view the full press release, visit http://ibn.fm/DnjZw

About Blue Hat

Blue Hat Interactive Entertainment Technology is a producer, developer and operator of augmented reality (“AR”) interactive entertainment games and toys in China, including interactive educational materials, mobile games, and toys with mobile game features. Its interactive entertainment platform brings unique user experience by connecting physical items to mobile devices, which creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery.  Distinguished by its own proprietary technology, Blue Hat aims to create an engaging, interactive and immersive community for its users. For more information, visit the company’s website at www.BlueHatGroup.net.

NOTE TO INVESTORS: The latest news and updates relating to BHAT are available in the company’s newsroom at http://ibn.fm/BHAT

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Completes $3M Non-Brokered Private Placement; Announces Filing of Q2 Financials, Upcoming Conference Call

Global developer and provider of cellular communications systems Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)announced on Thursday its completion of a non-brokered private placement with a single investor of 7,500,000 units, each at a price of $0.40, for gross proceeds of $3,000,000. “We are very pleased with this additional injection of capital to strengthen our balance sheet and build on our inventory,” Marc Seelenfreund, CEO and director of Siyata stated in the news release. “Our Q3 has proven to be very strong and will be substantially higher than Q3 2018 due to US sales, while our sales opportunity pipeline is very robust and continues to grow as expected. There is growing demand for Push-to-Talk Over Cellular devices across industries worldwide, witnessed by our expanding carrier and specialized distribution channels and we are well-positioned to capitalize on this paradigm shift in the market.” In addition, Siyata this morning announced that it has filed its second quarter 2019 financials and will be hosting a conference call to discuss these results, along with a Q&A session with Siyata Mobile CEO and Chairman Marc Seelenfreund. The call is scheduled to be held on Tuesday, September 3, 2019 at 9:00 AM ET. Interested parties may access the call by dialing (866) 521-4909 (Toll-Free) or (647) 427-2311 (International Calls). A playback in MP3 format will be available by contacting investor relations at SIM@KinCommunications.com.

To view the full press releases, visit http://ibn.fm/b190M and http://ibn.fm/wBMsR

About Siyata Mobile Inc.

A TSX Venture Top 50 Company, Siyata Mobile Inc. is a leading global developer and provider of cellular communications systems for enterprise customers, specializing in connected vehicle products for professional fleets, marketed under the Uniden® Cellular brand. Since developing the world’s first 3G connected vehicle device, Siyata has been a pioneer in the industry, launching the world’s first 4G LTE all-in-one fleet communications device in 2017. Incorporating voice, push-to-talk over cellular, data, and fleet management solutions into a single device, the company aims to become the connected vehicle communications device of choice for commercial vehicles and fleets around the world. Siyata also offers rugged phones for industrial users and signal boosters for homes, buildings, and fleets with poor cell coverage. Siyata’s customers include cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia, and the Middle East. For more information, visit www.SiyataMobile.com and www.UnidenCellular.com.

NOTE TO INVESTORS: The latest news and updates relating to SYATF are available in the company’s newsroom at http://ibn.fm/SYATF

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Releases Fiscal 2019 Q2 Financial Results, Achieves $5.9M Revenue Milestone

IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3) on Thursday released its second quarter 2019 financial results as it achieves a $5.9M revenue milestone for the first half of year. The company reported highlights for the quarter ended June 30, 2019 that include completion of a number of strategic acquisitions, as well as a concurrent brokered and non-brokered debenture unit offering raising approximately C$20 million in gross proceeds. “We are very pleased with our second quarter financial results, achieving our focus of increasing sales growth while closing a successful financing for various strategic business acquisitions all in a span of three months,” John Gorst, chairman and CEO of IONIC Brands said in the news release.

To view the full press release, visit http://ibn.fm/hZ6d4

About IONIC Brands Corp.

IONIC Brands is focused on building a multi-state consumer-focused cannabis concentrate brand portfolio focusing on the premium and luxury segments. The cornerstone brand of the portfolio, IONIC, is the No. 1 vaporizer brand in Washington State and has aggressively expanded throughout the West Coast of the United States. The brand is currently operating in Washington, Nevada, Oregon and California. IONIC BRANDS’ strategy is to be the leader of the highest-value segments of the cannabis market and expand nationally. For more information, visit the company’s website at www.IONIC.social.

NOTE TO INVESTORS: The latest news and updates relating to IONKF are available in the company’s newsroom at http://ibn.fm/IONKF

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Portfolio Company Acquires Ultra-Premium Cannabis Brand

Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) on Thursday announced that its portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) has entered definitive agreements to acquire ABI SF, LLC. ABI SF operates a Bay Area cannabis cultivation facility and owns the State Flower brand, which is recognized for its ultra-premium cannabis flower. California-based cannabis producer State Flower focuses on its craft approach to cultivation, using first-class genetics at an Envirocann certified facility in San Francisco. “This announcement is yet another example of TerrAscend delivering on its U.S. expansion plans, providing ever-growing U.S. exposure to Canopy Rivers’ and TerrAscend’s shareholder base,” Canopy Rivers president and CEO Narbe Alexandrian stated in the news release. “We think the acquisition of State Flower will allow TerrAscend to capture important mindshare in the U.S. through a strong, consumer facing brand. With a U.S. retail foothold already secured through The Apothecarium, we believe that State Flower is a natural strategic fit for TerrAscend.”

To view the full press release, visit http://ibn.fm/Sxhmk

About Canopy Rivers Inc.

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers works collaboratively with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) to identify strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. For more information, visit the company’s website at www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://ibn.fm/CNPOF

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Why Quest Patent Research Corp. (QPRC) Is ‘One to Watch’

New York City-based Quest Patent Research (OTCQB: QPRC) is an intellectual property (“IP”) asset-management firm that delivers financial, strategic and legal resources for IP monetization via majority-owned and controlled operating subsidiaries. A recent article discussing the company reads, “Quest creates shareholder value through investment and management interests in intellectual property assets, such as patents, trademarks, copyrights, novel inventions and trade secrets. Through its business, shareholders have the opportunity to participate across a broad portfolio of dynamic assets in the burgeoning intellectual property space. . . . Invention, protection and commercialization of IP require a deep understanding of dynamic technologies, market fundamentals, competitive landscapes and engagement strategies. Often, IP asset owners/stakeholders lack the requisite resources, experience and/or capacity to access the latent value of their IP assets and opportunities.”

To view the full article, visit http://ibn.fm/4bazl

About Quest Patent Research Corp.

Quest Patent Research operates as an intellectual-property, asset-management company delivering financial, strategic and legal resources for IP monetization. It partners with inventors, businesses, corporations and law firms to fully realize the value of IP assets through its suite of value-added services. Quest currently owns, controls or manages more than 115 patents across 11 intellectual property portfolios. Quest trades on the OTCQB Venture Market for early stage and developing U.S. and international companies. Companies are current in their reporting and undergo an annual verification and management certification process. For more information, visit the company’s website at www.QPRC.com.

NOTE TO INVESTORS: The latest news and updates relating to QPRC are available in the company’s newsroom at http://ibn.fm/QPRC

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: A2PL) Enters Alternative Cannabis Consumption Space via Strategic Acquisition

Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: A2PL), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, recently announced that is has acquired 49% of Cannova Medical Ltd. (http://ibn.fm/gtyG6). Based in Israel, Cannova is a provider of innovative solutions for cannabis consumption, such as sublingual strips. An article discussing the company reads, “According to Cannova, the use of sublingual strips allows for better control of dosage quantities and an enhanced effect of active compounds. These sublingual strips can be used to achieve an array of goals like pain management, enhanced sleep quality and depression control. . . . As per the terms of agreement between the two entities, Nabis Holdings has purchased 2,260,500 common shares that represent 49% of Cannova, with the option to acquire the remaining 51% interest. Nabis will retain exclusive distribution rights to the Cannova sublingual strips and all of the related technology.”

To view the full article, visit http://ibn.fm/ozhUf

About Nabis Holdings Inc.

Nabis Holdings is a Canadian investment issuer that invests in high-quality, cash-flowing assets across multiple industries, including real property, securities, cryptocurrency, and all aspects of the U.S. and international cannabis sector. Led by two of the co-founders of MPX Bioceutical, one of the largest takeovers in the U.S. cannabis space to date, the company has a proven track record in emerging markets to create significant shareholder value. The company is focused on investing across the entire vertically integrated aspects of the space with a focus on revenue generation, EBITDA and growth. For more information, please visit www.NabisHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to NABIF are available in the company’s newsroom at http://ibn.fm/NABIF

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – MustGrow Biologics Corp. (CSE: MGRO) Focuses on Optimizing Liquid Pest-Control Formulation

MustGrow Biologics (CSE: MGRO), an agricultural biotech company, is concentrating its efforts toward the development of a liquid formulation that will support fruit, vegetable, turf, ornamental, tobacco and cannabis products. A recent article discussing the company reads, “MustGrow’s scientific focus this year is on using funds to optimize its liquid formulation and to research the potential for cannabis application. In addition, it is looking to bring in third-party products for the cannabis market under distribution and in-licensing agreements. The first of these third-party products includes an agreement with Triangle Plant Sciences (‘TPS’) to offer exclusive Canadian and global access to TPS’s TP-1000, a bio-fertility product that, based on third-party studies, can increase cannabis yields by approximately 5%,  THC levels by 10% and terpenes by 22% . . . . ‘This is an exciting time to launch a TPS and MustGrow partnership that will deliver TPS’s best-in-class nutrient technology solutions for MustGrow’s high-value hydroponic applications, including cannabis in production legal geographies,’ senior product director at TPS Nick Favret stated after announcing the agreement last month. ‘Third-party indoor trials have demonstrated excellent performance in hydroponic cannabis applications, with significant increases in terpene, and tetrahydrocannabinol (THC) concentration.’”

To view the full article, visit http://ibn.fm/DKRvq

About MustGrow Biologics Corp.

MustGrow is an agricultural biotech company focused on developing and commercializing its patented natural biologic product that acts as a pesticide, fungicide nematicide and fertilizer. Targeting the fruit, vegetable, turf, ornamentals and cannabis industries, MustGrow has designed a U.S. EPA-approved organic solution that uses the mustard seed’s natural defense mechanisms to protect plants from pests and diseases. Approximately $9 million has been spent on 110 independent tests, validating MustGrow’s remarkably safe and effective granular product. MustGrow’s granular product is EPA approved across all key U.S. states as a fertilizer and pesticide (currently limited to fertilizer in California) and is designated by Health Canada’s Pest Management Regulatory Agency as a fruit, vegetable, turf and ornamental biopesticide and biofertilizer. In the cannabis space, MustGrow is currently developing reliable, safe and biological solutions that adhere to Health Canada’s strict regulations. MustGrow is positioning its signature product as an effective preplant soil treatment, reducing the chance for any added soil to a greenhouse to bring in pests or diseases. MustGrow expects its biopesticide and biofertilizer will help licensed cannabis producers control the same conditions addressed in fruit and vegetable crops. For more information, visit the company’s website at www.MustGrow.ca.

NOTE TO INVESTORS: The latest news and updates relating to MGRO are available in the company’s newsroom at http://ibn.fm/MGRO

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Neutra Corp. (NTRR) Building Vertically with Hemp Market Acquisitions to Improve Human Body, Global Environment

• Texas-based Neutra Corp. produces nutraceutical vapor products and is expanding into hemp cultivation and purified hemp extract products
• The wellness product industry measures in the trillions of dollars, growing faster than the global economy, and the hemp cultivation industry is expected to top $26 billion by 2025
• The LOI for Vivis would grant Neutra Corp. an established brand of products built on crystalline CBD and full-spectrum CBD extract, while the J3 Holdings LOI would deliver land, a warehouse and a license to cultivate and refine hemp

The growing focus on health and wellness products and philosophies during recent decades has created a bustling marketplace in which businesses and consumers work collaboratively on wallet-friendly ways to love life in the living of it. Neutra Corp. (OTCQB: NTRR) is an interested player in the arena, advancing its interests in monetizing early stage research and development efforts to build a better human body and global environment by growing vertically within the nutraceuticals, food and drug, and environmental purification sectors.

Neutra Corp. has recently pursued the acquisition of companies that hold licenses to cultivate and process hemp, and to sell established high quality, high potency hemp-extracted products, through letters of intent that would bring the subsidiaries’ strengths into the fold.

The Global Wellness Institute reported last fall that the wellness industry grew by 6.4 percent each year from 2015 to 2017, topping $4.2 trillion as a market growing nearly twice as fast as the global economy (http://ibn.fm/FyvcI) as a result of concerns over the rising costs of health care and growing reporting of select chronic ailments among younger-than-traditional populations. The global hemp industry is expected to experience a CAGR of 34 percent from now to 2025, according to Research and Markets analysts, growing from $4.6 billion to $26.6 billion (http://ibn.fm/yEW8k).

Neutra Corp.’s efforts to develop its portfolio demonstrate its recognition of the market factors in play, as well as its conscientiousness in making a quality of life difference for people. Medical-grade hemp extracts have gained a reputation for helping people to manage pain and anxiety, whether from chronic diseases, athletic injuries or everyday aches and pains.

The company has entered two LOIs for emerging hemp retail brand Vivis and hemp cultivator J3 Holdings. The Vivis acquisition “will give Neutra Corp. an even stronger market presence with an established brand already recognized for superiority,” Neutra Corp. President and CEO Sydney Jim stated in a news release (http://ibn.fm/vtDdG).

Vivis has a product line that uses a 99 percent or higher grade of hemp-extracted crystalline CBD, and the firm is preparing to launch a second brand with an 80 percent or higher grade of full-spectrum CBD extract. Vivis’ extracts are certified by a third-party lab to ensure their quality.

J3 Holdings has land, a warehouse and a license to cultivate and refine hemp that are expected to prove valuable additions to Neutra Corp.’s stable.

For more information, visit the company’s website at www.NeutraInc.com

NOTE TO INVESTORS: The latest news and updates relating to NTRR are available in the company’s newsroom at http://ibn.fm/NTRR

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Gains Media Attention Following Four Profitable Quarters

Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, recently received coverage in a Bloomberg article discussing OGI’s financial results for the last four quarters (http://ibn.fm/BUMhB). An article further discussing the company reads, “Organigram’s Q3 and fiscal year-to-date results represent some of the strongest operating and financial metrics amongst Canadian licensed producers. With one of the lowest cultivation costs per gram and continued discipline on selling, general and administrative expenses, Organigram’s results place it in the top tier of the Canadian industry. . . . As per the Bloomberg article, Organigram’s sustainable profitability is an outlier due to the fact that the industry has been experiencing some negative developments. Regulatory measures have been undertaken in Canada against some of the cultivators to ensure compliance. Other firms have been registering lower than expected sales, significant negative-adjusted EBITDA and shrinking margins in recent quarters.”

To view the full article, visit http://ibn.fm/Xes7D

About Organigram Holdings Inc.

Organigram Holdings is a TSX Venture Exchange and NASDAQ Global Select-listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing the highest-quality, indoor-grown cannabis for patients and adult-recreational consumers in Canada, as well as developing international business partnerships to extend the company’s global footprint. Organigram has also developed a portfolio of legal adult-use recreational cannabis brands including the Edison Cannabis Company, Ankr Organics, Trailer Park Buds and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick, and the company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). For more information, visit the company’s website at www.Investors.Organigram.ca.

NOTE TO INVESTORS: The latest news and updates relating to OGI are available in the company’s newsroom at  http://ibn.fm/OGRMF

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Grapefruit Boulevard Investments Inc. (IGNG) Dedicated to Offering High-Quality Cannabis Products

California-based Grapefruit Boulevard Investments, a wholly owned subsidiary of Imaging3 (OTCQB: IGNG), is devoted to offering high-quality cannabis products. An article discussing the company reads, “Grapefruit’s dedication to quality and service means that, in addition to being able to offer a large and diverse inventory of superior cannabis products that can be delivered within 24 hours of order, the company’s wholesale distribution arm will also offer high-quality, competitively priced raw materials to other manufacturers and distributors. Grapefruit’s extraction lab produces high-quality distillate or ‘honey oil,’ a universal product used in everything from infused edibles and tinctures/creams to the ‘fuel’ used in vapes and e-cigarettes. Honey oil is a highly sought-out item on the cannabis market, and Grapefruit’s commitment to premium quality ingredients will enable the company to demand top dollar for its cannabis products. Utilizing biomass cultivated in its own indoor grow canopy operation, Grapefruit aims to position itself for high revenue potential.”

To view the full article, visit http://ibn.fm/fINLl

About Grapefruit Boulevard Investments Inc.

Grapefruit Boulevard Investments, a wholly owned subsidiary of Imaging3 Inc. (OTCQB: IGNG), holds California permits and licenses to both manufacture and distribute cannabis products. Grapefruit’s cannabis and CBD extraction laboratory and distribution facilities are located in the industry recognized as Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs. Grapefruit obtained its California cannabis licenses in January 2018 and commenced distribution of cannabis products thereafter. Grapefruit’s vision is to become a seed-to-sale, fully vertically, integrated ethical and compliant cannabis and CBD product company. For more information, visit the company’s website at www.GrapefruitBlvd.com.

NOTE TO INVESTORS: The latest news and updates relating to IGNG are available in the company’s newsroom at http://ibn.fm/IGNG

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php